RANBAXY INKS PACT WITH EPIRUS SWITZERLAND
NEW DELHI (TIP): Drug maker Ranbaxy Laboratories has entered into a licensing agreement with Epirus Switzerland GmbH, the Swiss arm of Boston-based Epirus Biopharmaceuticals Inc, for introducing a biosimilar version (BOW015) of infliximab, a drug […]
